Funding opportunities

About: the objectives of this grant opportunity offers funding to support medical research and medical innovation programs of research that deliver a ‘moonshot’ by creating a treatment for a currently serious and incurable health condition, through a series of linked projects. The program of research can propose to develop novel health technologies and/or re-purpose existing health technologies in a novel way.The process to get funding has two stages:expression of interest – outlining a proposed program of research with a 10-year time horizonfull application, for a project of up to five years under the program of research.Full applications may be submitted by invitation only. Applicants may propose to start research at any stage in the research pipeline from proof-of-concept, with the intention of achieving full implementation of the proposed technology in 10 years.Funding for subsequent projects under the program of research that continue to progress the technology towards full implementation can be sought by submitting additional full applications to this grant opportunity (i.e. applicants do not need to recommence with an EOI). These applications may be submitted by invitation only.It is expected that expressions of interest will close on 31 March 2026, with the last grants awarded by 30 June 2027. However, the closing date for expressions of interest may be altered if:the available funds are exhausted or insufficient to fund additional grants, in which case the closing date may be brought forwardfurther funds are made available in future years, in which case the closing date may be extended.Apply via: DISER (via portal)Key DatesOpening date in DISER: 13 February 2023Strategic review (optional): four weeks prior to the date you wish to submit, select time in the strategic booking calendarCompliance and eligibility check (mandatory): two weeks prior to the date you wish to submit, select your date and time in the compliance and eligibility booking calendar.Applicant submits final application in DISER: when application is compliant and all approvals are obtained in PURE

About: This grant opportunity is the first under the $50.0 million Primary Health Research Plan, which was developed by an independent Expert Advisory Panel in mid-2023.The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• Stream 1 (Aim 1, Objective #1 of Research Plan; Targeted Call for Research): details provided above
• Stream 2 (Aim 1, Objective #2 of Research Plan; Targeted Call for Research): details provided above
• Stream 3 (Aim 3 of Research Plan; Targeted Call for Research): details provided above
• Stream 4 (Aim 2 of Research Plan; Targeted Call for Research): develop and implement multidisciplinary, collaborative, regional consortia that design, implement and evaluate (including cost-benefit analyses) system-level reform strategies for local health system integration. Research proposals in this Stream must focus on one of the following topics:
  • Topic A: The organisation undertaking the majority of the research is based in any area according to the Modified Monash Model Locator (MM1-7)
  • Topic B: The organisation undertaking the majority of the research, the Chief Investigator A and 50% or more of all Chief Investigators, and all research participants are primarily resident in a rural, regional or remote area according to the Modified Monash Model Locator (MM2-7).

Note: This grant opportunity is intended to support projects that progress research that addresses a specific health need. For all Streams, applications must clearly demonstrate activities for capacity building for primary care practitioners and early career clinicians and/or researchers, including salary stipends for PhD scholarships or clinician time where relevant.

Applicants should also note the additional eligibility criteria that apply to individuals or organisations for this grant opportunity.

Applicants must nominate a Chief Investigator A (CIA) who will take the lead role in completing the application, conducting the research, and reporting as required under the grant agreement. A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, both applications will be considered ineligible.

For applications to Streams 1, 2 and 4, the Chief Investigator A must be a Primary Care Clinician Researcher, and 20% or more of the CI team must be Early to Mid-Career Researchers or Early Career Clinician Researchers.

For applications to Stream 3, 20% or more of the CI team must be Early to Mid-Career Researchers or Early Career Clinician Researchers.

For Stream 4, the Primary Health Research Plan requires that the proposed research will:

• bring together Primary Health Networks, local health networks/districts, local primary care practices, Aboriginal Community Controlled Health Services, pharmacies and other health care providers
• facilitate integration of healthcare, including service integration to improve patient access to quality care by overcoming barriers between services such as, but not limited to, specialist and hospital services, primary care, mental health, aged care, community and disability services
• evaluate how local services work together to commission or jointly fund multidisciplinary, person-centred care
• bring together existing funding mechanisms already available from partners for service delivery in innovative ways, to
• create new funding packages, to ensure sustainability beyond the life of the project
• assess feasibility, costs and cost effectiveness
• embed co-design with consumers and health services in all aspects of research design and implementation and
• address health issues that are a priority for the community including timely access to information.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by: -

Stream 4 (Aim 2 of the Research Plan; Targeted Call for Research): improving the patient journey through the interface between primary, secondary and tertiary care with the goal of achieving seamless transitions.

Funding and grant period

Stream 4: The maximum funding available s $2.8 million, and maximum grant period is 5 years.

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 18 October 2023
• Strategic review (optional): On or before 8-9 July, 2024 (book via this link)
• Minimum data deadline(Stream 4): 5pm ACT local time on 10 July 2024
• Compliance and Eligibility check (mandatory): On or before 23-24 July 2024 (book via this link)
• Applicant submits final application in Sapphire (Streams 4): 5pm ACT local time on 4 August 2024
• Research Services submission to MRFF(Stream 4): 5pm ACT local time on 07 August 2024
• Expected outcomes (Stream 4): December 2024

About: The objective of this grant opportunity is  to provide grants of financial assistance to support medical research and medical innovation projects that:

Stream 1 (Priority Area 3.1, Targeted Call for research): conduct implementation research focused on addressing inequalities in access to high-quality care for older Australians from diverse and disadvantaged backgrounds including, but not limited to:

• people from Aboriginal and/or Torres Strait Islander communities
• people from culturally and linguistically diverse backgrounds
• people who live in rural or remote areas o people who are financially or socially disadvantaged
• people who are veterans of the Australian Defence Force or an allied defence force, including the spouse, widow or widower of a veteran
• people who are homeless or at risk of becoming homeless
• people who are care leavers (including Forgotten Australians, Former Child Migrants and Stolen Generations)
• parents separated from their children by forced adoption or removal
• people from lesbian, gay, bisexual, trans/transgender, intersex and queer (LGBTIQ+) communities
• prisoners and ex-prisoners.

Stream 2 (Priority Area 3.1, Incubator): conduct small-scale development projects to develop innovative new approaches for providing optimal care for vulnerable people.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:

• Stream 1 (Priority Area 3.1, Targeted Call for Research): improving the equity of access to quality care for all older Australians
• Stream 2 (Priority Area 3.1, Incubator): improving care for vulnerable people

Applications to this grant opportunity must propose research that addresses one of the two Streams of research.

Note: A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, both applications will be considered ineligible.

Funding

The amounts available for a single grant in each Stream are as follows:

• Stream 1 (Priority Area 3.1, Targeted Call for Research): There is no minimum grant amount and the maximum amount available for a single grant is $3.0 million; The maximum grant period is 5 years
• Stream 2 (Priority Area 3.1, Incubator): the minimum grant amount is $0.2 million, and the maximum amount for a single grant is $1.0 million; The maximum grant period is 2 years

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 14 February 2024
• Strategic review (optional): On or before 9-10 July, 2024 (book via this link)
• Minimum Data Due: 5pm ACT local time on 10 July 2024
• Compliance and Eligibility check (mandatory): On or before 24 July 2024 (book via this link)
• Applicant submits final application in PURE: Sunday 04 August 2024
• Research Services submission to MRFF(Stream 4): 5pm ACT local time on 07 August 2024
• Expected outcomes: January – February 2025

About: The objective of this one-off grant opportunity is  to provide grants of financial assistance to support  projects that:

1. Programs of small-scale research projects identified as important by health services and their communities to improve health care.
2. Partnerships that foster collaboration between researchers, health service providers and end users, including consumers and community

Funding will be available under two application streams:

• Stream 1: Metropolitan-based (MM1)
• Stream 2: Regional/rural/remote (RRR)-based (MM2-7)

The intended outcomes of this grant opportunity are that:

1. Research translation and innovations in health care and practice are stimulated, with research outcomes showing potential for scalability.
2. Increased collaboration between research, health service providers and communities occurs, building research and translation capability.

It is expected that the outcomes from this grant opportunity will create a pathway to larger scale research translation and collaboration schemes.

Applications from existing health care/research collaborations that include at least one research and one health service provider that have a proven track record in co-design and research that delivers health outcomes are encouraged.

Note: Refer to grant guidelines for further information on Chief Investigators.

The maximum number of Chief investigators (CIs) allowed is 10.

At the time of acceptance and for the duration of a grant the CIA must be an Australian or New Zealand citizen, or a permanent resident of Australia, or have an appropriate work visa in place. The CIA must also be based in Australia for at least 80% of the funding period.

For applications to Stream 2, the CIA must be primarily resident in a Modified Monash Model 2-7 (MM 2-7) location (i.e. have been resident in an MM2-7 location for at least 12 months prior to the date of submission of the application).

Funding and Grant Period:

A 2024 Collaborations in Health Services Research grant is awarded for a fixed 2-year term. The maximum amount of funding that can be requested under this scheme is $1.0 million. A grant is expected to fund at least 5 projects.

Managing Agency:  NHMRC((via Sapphire)

• Opening Date: 12 June 2024
• Strategic review (optional): On or before 26 August, 2024 (book via this link)
• Minimum Data Due: 17:00 ACT local time 28 August 2024
• Compliance and Eligibility check (mandatory): On or before 04 September 2024 (book via this link)
• Applicant submits final application in PURE: Sunday 15 September 2024
• Research Services submission to MRFF(Stream 4): 5pm ACT local time on 18  September 2024
• Expected outcomes: First Quarter 2025

About: The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical innovation projects that use novel methods to harness multiple existing data infrastructure types in developing and implementing new approaches for addressing an unmet medical need.

For the purposes of this grant opportunity, unmet medical need arises where individuals are living with a serious health condition where there are limited satisfactory options for prevention, diagnosis or treatment to support improved health outcomes.

Examples of such projects may include (but are not limited to):

• use of clinical quality registries linked to other forms of research data infrastructure such as administrative datasets to generate new knowledge and/or actionable outcomes in an area of unmet medical need, noting that advances in epidemiological and biostatistical methods have 2 Ahern et al., Realising the potential: leveraging clinical quality registries for real world clinical research. Medical Journal of Australia, Volume 216, Issue 6 p. 273-277 Page 7 of 38 broadened the scope of questions that can be addressed through observational studies such as registries .
• using new methodologies to analyse existing complex linked datasets from multiple sources, or new linkages between existing datasets in populations that require large sample sizes or detailed data regarding priority populations2 with a focus on areas that will change practice.
  For the purposes of this grant opportunity, types of ‘research data infrastructure’ include clinical quality registries, biobanks, data collections, linkage platforms, data collection from wearables, use of artificial intelligence and informatics.

To meet the objective of the grant opportunity projects proposed should articulate a clear research question that addresses an area of unmet medical need, and explain how the proposed project will produce knowledge and outcomes that address the research question. Research proposals should incorporate:

• new linkage and/or use of data from multiple (at least two) existing research data infrastructure sources of different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence); and/or
• novel methodologies and approaches that leverage and enhance existing linked research data infrastructure of at least two different types (e.g. administrative and biobank data, registry and biobank data, wearables and use artificial intelligence)

Funding and Grant Period:

The maximum amount available for a single grant is $2.5 million for maximum of 4 years. The grant amount will be up to 100 per cent of eligible project costs (grant percentage).

About:

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• Stream 1 (Targeted Call for Research): conduct a large scale multidisciplinary project, in partnership with consumers and health services, to identify and evaluate the risk and impact of increased access to alcohol on physical and mental health for:
  Topic A: First Nations individuals and communities
  Topic B: adolescents and young adults.
• Stream 2 (Targeted Call for Research): conduct a large scale multidisciplinary project, in partnership with consumers and health services, to identify and evaluate the risk and impact of polysubstance use and/or the use of new psychoactive substances on physical and mental health for:
  Topic A: First Nations individuals and communities
  Topic B: adolescents and young adults.
• Stream 3 (Targeted Call for Research): develop, implement and/or evaluate patient-centred approaches for the treatment of substance use disorders, through co-design with health services and consumers, for:
  Topic A: First Nations individuals and communities
  Topic B: adolescents and young adults
  Topic C: women.
• Stream 4 (Incubator): develop new approaches for pain management for individuals with a current or past substance use disorder, focusing on:
  Topic A: pharmacological approaches
  Topic B: non-pharmacological approaches.

Streams 1, 2 and 3 are intended to support projects that progress research that addresses a specific health need.
Stream 4 is intended to support early stage, small scale research projects that seek to assess the potential and feasibility of novel strategies to address critical or intractable health issues.
Applicants should note the additional eligibility criteria that apply to individuals or organisations for this grant opportunity.

Additional information for Streams 1, 2 and 3
Applications to Topic A in Streams 1-3 are required to demonstrate leadership by First Nations individuals and communities in the design and implementation of the proposed research.
For the purposes of Topic B in Streams 1-3, adolescents and young adults are defined as people that are 14-24 years of age.

Note: A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, all of the applications will be considered ineligible.

Funds available:

The amounts available for a single grant in each Stream are as follows:

• Stream 1: The maximum amount available for a single grant is $2.0 million and maximum grant period is 5 year.
• Stream 2: The maximum amount available for a single grant is $2.0 million and maximum grant period is 5 year.
• Stream 3: The maximum amount available for a single grant is $3.0 million and and maximum grant period is 5 year
• Stream 4: The maximum amount available for a single grant is $1.0 million and maximum grant period is 2 years.

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 17 Jul 2024
• Strategic review (optional): On or before 9 October 2024 (book via this link)
• Minimum Data Due: 5pm ACT local time on 9 October 2024
• Compliance and Eligibility check (mandatory): On or before 23 October 2024(book via this link)
• Applicant submits final application in PURE: Sunday 03 November 2024
• Research Services submission to MRFF: 6 Nov 2024 5:00 pm (ACT Local Time)

About:

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• Stream 1. (Incubator): conduct small-scale research to develop novel treatments and/or management strategies for:
  • Topic A: chronic pain as a result of injury
  • Topic B: chronic pelvic pain, chronic pain due to endometriosis or other chronic pain experienced by women
  • Topic C: other types of chronic pain.
• Stream 2. (Incubator): conduct a pilot study to assess the feasibility of a clinical trial for one or more novel treatments and/or management strategies for:
  • Topic A: chronic pain as a result of injury
  • Topic B: chronic pelvic pain, chronic pain due to endometriosis or other chronic pain experienced by women
  • Topic C: other types of chronic pain.

The intended outcome of the research is to improve the health and wellbeing of Australians by developing effective approaches for treating people with chronic pain.

Note: A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, both applications will be considered ineligible.

Funds Available and Period:

• Stream 1: The maximum amount available for a single grant is $1.0 million for period of 2 years.
• Stream 2: The maximum amount available for a single grant is $0.8 million for period of 2 years.

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 17 Jul 2024
• Strategic review (optional): On or before 9 October 2024, 2024 (book via this link)
• Minimum Data Due: 5pm ACT local time on 9 October 2024
• Compliance and Eligibility check (mandatory): On or before 23 October 2024 (book via this link)
• Applicant submits final application in PURE: Sunday 03 November 2024
• Research Services submission to MRFF: 6 Nov 2024 5:00 pm (ACT Local Time)

About:

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• Stream 1: identify and/or evaluate the physical, emotional and/or psychological impacts of fertility treatment and its outcomes on prospective parents.
• Stream 2: conduct a large-scale multidisciplinary project, co-designed with consumers, to identify the barriers and enablers to, and impact of, evidence-based help-seeking behaviour among parents when concerned during pregnancy.
• Stream 3: identify and/or validate new predictive markers of pregnancy loss risk and/or adverse outcomes across the pregnancy continuum.
• Stream 4: conduct a large-scale multidisciplinary project, co-designed with consumers, to identify and evaluate the impacts of perimenopause and menopause on health and wellbeing. Applications are required to:  
  • investigate menopause symptoms that impact on physical health, mental health and wellbeing, including psychosocial factors
  • investigate impacts on workforce engagement and retention, including on paid and unpaid employment
  • include research participants from metropolitan areas (MM1) and regional, rural and/or remote locations (MM2-7), according to the Modified Monash Model
  • consider diverse populations (e.g. individuals from culturally and linguistically diverse communities).
• Stream 5: investigate the biological mechanisms or risk factors that underpin:   
  • Topic A: unexplained female infertility
  • Topic B: pregnancy loss and/or neonatal death
  • Topic C: early or medically induced menopause.

  Note: A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, all of the applications will be considered ineligible.

Funds Available and Period:

• Stream 1: The maximum amount available for a single grant is $2.0 million and maximum period can be 5 years.
• Stream 2: The maximum amount available for a single grant is $3.0 million and maximum period can be 5 years..
• Stream 3: The maximum amount available for a single grant is $2.0 million and maximum period can be 5 years..
• Stream 4: The maximum amount available for a single grant is $5.0 million and maximum period can be 5 years.
• Stream 5: The maximum amount available for a single grant is $1.0 million and maximum period can be 3 years.

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 17 Jul 2024
• Strategic review (optional): On or before 9 October 2024 (book via this link)
• Minimum Data Due: 5pm ACT local time on 9 October 2024
• Compliance and Eligibility check (mandatory): On or before 23 October 2024 (book via this link)
• Applicant submits final application in PURE: Sunday 03 November 2024
• Research Services submission to MRFF: 6 Nov 2024 5:00 pm (ACT Local Time)

About:

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that:

• promote Australian involvement in international collaborative investigator-initiated clinical trials
  research through the establishment and co-ordination of clinical trial site/s in Australia.
• provide high-quality evidence of the effectiveness of novel health treatments, drugs or devices in
  ‘usual care’ settings, which will support a decision on whether to deliver the intervention in an
  Australian setting.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by investing in new clinical trials that support increased access to high-quality, evidence-based and effective health care.

This grant opportunity is intended to support projects that progress research that addresses a specific
health need. For the purposes of this grant opportunity, novel health treatments can include innovative applications of
existing interventions.

Applications to this grant opportunity must propose a clinical trial in Australia in collaboration with
international counterparts. The clinical trial should not have commenced recruitment at the Australian trial
site/s.

NOTE: Applicants must nominate a Chief Investigator A (CIA) who will take the lead role in completing the
application, conducting the research, and reporting as required under the grant agreement.

A person must not be named as a Chief Investigator (CI) on more than one application submitted to a
Round of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application
per Round). If a CI is named on more than one application submitted to a Round of this grant opportunity,
both applications will be considered ineligible.

Funds Available and Period:

The maximum amount available for a single grant is $3.0 million and maximum grant period that can be applied for is five years.

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 6 March 2024
• Strategic review (optional): On or before  06 Jan 2025 (book via this link)
• Minimum Data Due: : 5pm ACT local time on 4 December 2024
• Compliance and Eligibility check (mandatory): On or before 0 7 Jan 2025 (book via this link)
• Applicant submits final application in PURE: Sunday 02 Feb 2025
• Research Services submission to MRFF: 5pm ACT local time on 5 February 2025

About:

The objective of this grant opportunity is to provide grants of financial assistance to support Australian medical research and medical
innovation projects that:

• Stream 1 - Innovation enablers (Targeted Call for Research)
  address an area of unmet medical need by promoting the development and implementation of
  new research infrastructure by supporting development and/or expansion of research enablers
  such as biobanks, tissue repositories, novel research platforms, and secure health data
  environments to create valuable research resources.
• Stream 2 - Digitisation of health care (Targeted Call for Research)
  develop and translate into practice digital therapeutics, artificial intelligence enabled health
  interventions and technologies (e.g. wearables integrated into clinical practice), applications or
  other software for use in clinical practice.
• Stream 3 - Co-investment partnerships (Targeted Call for Research)
  utilise co-investment (cash only) with the research sector, state and/or territory governments,
  and industry, in significant critical research infrastructure (e.g. facilities, personnel and
  equipment):
  • to support development of research capacity, capability and/or effectiveness in an area of
    unmet medical need, or
  • to enable Australian research using new platforms, systems and services in an area of
    unmet medical need.
• Stream 4 - mRNA technology enablers (Targeted Call for Research)
  leverage and enhance emerging mRNA technologies, platforms, and/ or equipment to
  accelerate develop

Additional information for Stream 2 For applications to Stream 2, artificial intelligence technologies may include machine learning, natural language processing, speech recognition, computer vision, and automated reasoning techniques.

Additional information for Stream 3
Stream 3 is structured to incentivise partnerships between academia, governments and industry that can generate knowledge and/or interventions that can transform health practice.

Additional information for Streams 3 and 4
For the purposes of Streams 3 and 4 of this grant opportunity, ‘platforms, systems and services’ may include:  tools for enabling interdisciplinary research cooperation (‘platforms’)  artificial intelligence, software, quality control research management (‘systems’)  provision of scientific or technical expertise and resources; skilled personnel required to run facilities, systems, equipment and platforms; capability building; and professional development (‘services’).

Applications to this grant opportunity must propose research that addresses one of the four Streams of research. An application may only be submitted to one of the above four Streams only. Applicants must specify the Stream to which they are applying in their application.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by enhancing Australia’s research infrastructure to promote new research approaches that will address health challenges by generating new knowledge and improving health outcomes.

Funds Available and Period:

• Stream 1 (Targeted Call for Research):The maximum amount available for a single grant is $3 million.
• Stream 2 (Targeted Call for Research): The maximum amount available for a single grant is $3 million.
• Stream 3 (Targeted Call for Research): The maximum amount available for a single grant is $7 million. Grants funded under Stream 3 will be funded under a co-funding model.
• Stream 4 (Targeted Call for Research): The maximum amount available for a single grant is $4 million.

Note:  All members of the research team must be listed on the application form as Chief Investigators (CIs). Applicants must nominate a Chief Investigator A (CIA) who will take the lead role in conducting the project and report on the outcomes of the project as specified in the grant agreement.

To facilitate collaborative research teams with the required capacity and capability to undertake the proposed research, up to 15 CIs may be included as members of the research team. If you include more than 15 CIs, your application will be ineligible.

A person must not be named as a Chief Investigator (CI) on more than one application submitted per stream to this grant opportunity. If a person is named as a CI on more than one application per stream, all of those applications will be considered ineligible.

Apply Via: Department of Industry, Science and Resources DISR

• Opening Date: 4-Oct-2024
• Strategic review (optional): On or before 03 March 2025 (book via this link)
• Compliance and Eligibility check (mandatory): On or before 17 March 2025 (book via this link)
• Applicant submits final application in DISR: When application is compliant and all approvals are obtained in PURE 5pm ACT local time on 5 February 2025

About:

The objective of this grant opportunity is to provide grants of financial assistance to support medical research and medical innovation projects that evaluate the effectiveness and feasibility of new or existing models of integrated, multidisciplinary team-based primary care for people who would most benefit from this type of care, including but not limited to First Nations Australians, people from culturally and linguistically diverse backgrounds, people with disability including intellectual, children, older populations (either in residential aged care homes or those ageing at home), or those with social disadvantage or multiple chronic conditions.
Cross-jurisdictional collaboration, where relevant, is encouraged and projects should consider sustainability and scalability of solutions beyond the project.

Three streams of funding are available based on the health service provider or geographic location of the organisation undertaking the majority of the research:

• Stream 1 (Targeted Call for Research): The organisation undertaking the majority of the research must be located in any area according to the Modified Monash Model (MM1-7)
• Stream 2 (Targeted Call for Research): The organisation undertaking the majority of the research is located in, and the Chief Investigator A and 50% or more of all Chief Investigators, and all research participants, are primarily resident in, a rural or remote area according to the Modified Monash Model (MM3-7)
• Stream 3 (Targeted Call for Research): The organisation undertaking the majority of the research must be an Aboriginal Community Controlled Health Service.

For all Streams, applications must clearly demonstrate activities for capacity building for primary care practitioners and early career clinicians and/or researchers including salary stipends for PhD scholarships or clinician time where relevant.

NOTE: Applicants should note the additional eligibility criteria that apply to individuals or organisations for this grant opportunity.

Applicants must nominate a Chief Investigator A (CIA) who will take the lead role in completing the application, conducting the research, and reporting as required under the grant agreement.

A person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream). If a CI is named on more than one application submitted to a Stream of this grant opportunity, both applications will be considered ineligible.

Funds Available and Period:

The amounts available for a single grant in each Stream are as follows: 

Stream 1: The maximum amount available for a single grant is $2.0 million; the maximum grant period is 5 years
Stream 2: The maximum amount available for a single grant is $2.0 million; the maximum grant period is 5 years
Stream 3: The maximum amount available for a single grant is $2.0 million; the maximum grant period is 5 years

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 11 September 2024
• Strategic review (optional): On or before  03  March 2025 (book via this link)
• Minimum Data Due: : 5:00pm (ACT Local Time) on 5 March 2025
• Compliance and Eligibility check (mandatory): On or before 19 March 2025 (book via this link)
• Applicant submits final application in PURE: Sunday 30 March 2025
• Research Services submission to MRFF: 2 Apr 2025 5:00 pm (ACT Local Time)

About:

This objective of this grant opportunity will support medical research and medical innovation projects that:
Stream 4 (Aim 3 of Research Plan):

• Stage 2 (Targeted Call for Research): establish a multidisciplinary national adaptive platform trial that accelerates assessment and implementation of therapeutic interventions (pharmacological and non-pharmacological) for PASC.

The intended outcome of the research funded by this grant opportunity is to improve the health and wellbeing of Australians by:

• Stream 4 (Aim 3 of Research Plan; Incubator and Targeted Call for Research): accelerating the identification of optimal management approaches for people living with PASC.

This grant opportunity is being administered by NHMRC on behalf of the Australian Government Department of Health and Aged Care.

NOTE: Additional information applies for Stream 4

Applicants must nominate a Chief Investigator A (CIA) who will take the lead role in completing the application, conducting the research, and reporting as required under the grant agreement. Applications to Stage 2 of Stream 4 can include Chief Investigators that were successful under Stage 1. Otherwise, a person must not be named as a Chief Investigator (CI) on more than one application submitted to a Stream of this grant opportunity (i.e. a person may be named as a CI on a maximum of one application per Stream).

Funds Available and Period:

The maximum grant duration is: Stream 4 Stage 2: 5 years

Managing agency: MRFF (via Sapphire)

• MRFF Opening Date: 06 September 2023
• Strategic review (optional): On or before )1 April 2025 (book via this link)
• Minimum Data Due: : 5:00pm (ACT Local Time) on 5 March 2025
• Compliance and Eligibility check (mandatory): On or before 16 April 2025 (book via this link)
• Applicant submits final application in PURE: Sunday 27 April 2025
• Research Services submission to MRFF: 5pm ACT local time on 30 April 2025

Lead Chief Investigator: Professor Jeffrey Braithwaite
Project title: Harnessing implementation science, complexity science and evidence-based care to Keep Australians Out of Hospital: leveraging seven natural experiments in New South Wales
Scheme: Keeping Australians out of Hospital
Funding total: $1,505,612

Lead Chief Investigator: Professor Ralph Martins
Project title: The Australian-multidomain Approach to Reduce dementia Risk by protecting brain health With lifestyle intervention (AU-ARROW) study
Scheme: MRFF International Clinical Trial Collaborations (ICTC) Program
Funding total: $3,115,063

Lead Chief Investigator: Professor Deborah Schofield
Project title: The health, economic and social consequences of genomic sequencing and cascade testing for intellectual disability.
Scheme: MRFF Genomics Health Futures Mission – Ethical, Legal and Social Issues Projects Grant
Funding total: $499,728

Lead Chief Investigator: Professor Viviana Wuthrich
Project title: Screening and Risk Reduction for Dementia in Primary Care
Scheme: 2020 Investigator Grants: MRFF Priority Round to commence in 2021 (EL2)
Funding total: $1,562,250

Lead Chief Investigator: Professor Catherine McMahon
Project title: Improving care pathways for Otitis Media in Aboriginal children (0-12): A case study approach
Scheme: 2019 MRFF Indigenous Health Research 2020
Funding total: $1,961,473.90

Lead Chief Investigator: Professor Sheila Degotardi
Project title: Harnessing the health communication power of the early childhood sector
Scheme: Coronavirus Research Response – 2020 Communication Strategies and Approaches During Outbreaks
Funding total: $174,992

Lead Chief Investigator: Professor Simon French
Project title: Determining the impact of a new primary care model for low back pain: A cluster randomised trial
Scheme: MRFF International Clinical Trial Collaborations (ICTC) Program
Funding total: $2,107,805.90

Lead Chief Investigator: Professor Piers Dawes
Project title: SENSEcog aged care: Hearing and vision support to improve quality of life for people living with dementia in residential aged care
Scheme: MRFF 2020 Dementia, Ageing and Aged Care Grant
Funding total: $1,200,710.20

Lead Chief Investigator: Professor Helen Rizos
Project title: Integrated Multimodal Precision Liquid biopsy to Enhance MElanoma and NSCLC Treatment (IMPLEMENT)
Scheme: MRFF 2020 Genomics Health Futures Mission
Funding total: $2,031,178.80

Lead Chief Investigator: Associate Professor Robyn Clay-Williams
Project title: Working together: innovation to improve Emergency Department (ED) performance, and patient outcomes and experience for five complex consumer cohorts
Scheme: 2022 MRFF Models of Care to Improve the Efficiency and Effectiveness of Acute Care
Funding total: $2,836,550.50

Lead Chief Investigator: Professor Johanna Westbrook
Project title: Transforming residential aged care through evidence-based informatics
Scheme: 2021 MRFF Dementia, Ageing and Aged Care Mission
Funding total: $992,386.00

Lead Chief Investigator: Dr Kylie Gwynne
Project title: Early Artial fibrillation Screening for Indigenous people (EASI)
Scheme: 2021 MRFF Cardiovascular Health Mission
Funding total: $574,883.90